YOSEMITE PATHOLOGY QUALITY DIAGNOSTICS FOR OPTIMUM PATIENT CARE

LIVE

Serial Number

87065058

Owner

Yosemite Pathology Medical Group, Inc.

Attorney

Rob G. Leach

First Use Date

Apr 30, 2016

Filing Date

Jun 8, 2016

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

YOSEMITE PATHOLOGY QUALITY DIAGNOSTICS FOR OPTIMUM PATIENT CARE Trademark

Serial Number: 87065058 • Registration: 5175122

YOSEMITE PATHOLOGY QUALITY DIAGNOSTICS FOR OPTIMUM PATIENT CARE is a trademark filed by Yosemite Pathology Medical Group, Inc. on June 8, 2016. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

Yosemite Pathology Medical Group, Inc. (15 trademarks)

Modesto, CA 953569262

Entity Type: 03

Legal Representation

Attorney of Record

Rob G. Leach

457 trademarks filed View all →

Correspondence Address

Rob G. Leach CHARMASSON, BUCHACA & LEACH, LLP

2635 Camino Del Rio S

Suite 102

SAN DIEGO, CA 92108

United States

Trademark Details

Filing Date

June 8, 2016

Registration Date

April 4, 2017

First Use Anywhere

April 30, 2016

First Use in Commerce

April 30, 2016

Published for Opposition

January 17, 2017

Goods & Services

Medical services; Medical services in the field of pathology

Laboratory analysis in the field of pathology; Medical laboratory services

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Aug 21, 2026 NA89

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Aug 21, 2026 RNL1

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Aug 21, 2026 89AG

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Aug 21, 2026 APRE

TEAS SECTION 8 & 9 RECEIVED

Jun 26, 2026 E89R

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Apr 4, 2026 REM2

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Nov 19, 2022 NA85

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Nov 19, 2022 C15A

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Nov 19, 2022 APRE

TEAS SECTION 8 & 15 RECEIVED

May 13, 2022 E815

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Apr 4, 2022 REM1

REGISTERED-PRINCIPAL REGISTER

Apr 4, 2017 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 17, 2017 NPUB

PUBLISHED FOR OPPOSITION

Jan 17, 2017 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 28, 2016 NONP

LAW OFFICE PUBLICATION REVIEW COMPLETED

Dec 12, 2016 PREV

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 23, 2016 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 21, 2016 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 21, 2016 CRFA

ASSIGNED TO LIE

Nov 8, 2016 ALIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 27, 2016 TROA

NOTIFICATION OF PRIORITY ACTION E-MAILED

Sep 22, 2016 GPRN

PRIORITY ACTION E-MAILED

Sep 22, 2016 GPRA

PRIORITY ACTION WRITTEN

Sep 22, 2016 CPRA

ASSIGNED TO EXAMINER

Sep 19, 2016 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Jun 16, 2016 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 15, 2016 NWOS

NEW APPLICATION ENTERED

Jun 11, 2016 NWAP

Related Trademarks

More from this Owner

YOSEMITE PATHOLOGY PRECISION PATHOLOGY QUALITY DIAGNOSTICS FOR OPTIMUM PATIENT CARE

GYNQ

More in Same Class

GRANDPARENTS HALL OF FAME EARNED IT

CROSS-REFERENCE TESTING SYSTEM